Thursday, September 05, 2019 10:36:32 AM
Greetings Dr. Wilkomm. I would like to ask a couple investor questions and pass the information along to friends and family who are also invested in Lifeloc:
In regards to the new breathalyzer platform with features that customers have demanded - You were expecting to begin limited production before the end of 2018 and be running at full scale production during this current quarter. Can you please provide an update on this status? Has this been completed and ready for roll out to those customers?
The upgraded RADAR device was expected to launch in the current quarter - Can you also provide an update on this status? I have noticed that Lifeloc is hiring for a business manager for the RADAR product line. Can I conclude that the upgraded RADAR device has been completed and is ready for roll out?
Has any human testing for the marijuana breathalyzer been commenced? Can we expect any updates on the SpixDX technology and the progress being made?
I would have liked to also see some effort taken in regards to being more active on social media. This was an area that I thought was being worked on but I continue to see minimal effort and lack of investor awareness.
Wayne's response:
Manufacturing did build a small number of units of our new breathalyzer platform before the end of 2018, with a number of build campaigns since then. The product has been sampled and introduced to key distributor customers. The RADAR redesign has been completed with early prototypes in testing now to turn over to manufacturing later this year for market reintroduction. We do not yet have results to report on human testing and we will report updates on the marijuana breathalyzer and SpinDx as soon as we have something solid to report. Yes I agree that we need a higher profile on social media and we have realigned some resources to do that, which I had hoped would have some more activity by now. Time to rattle that cage again.
Recent LCTC News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:14:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:46:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 02:57:07 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/23/2023 02:57:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 09:11:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:21:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM